Illumina CEO on Genomic Sequencing Opportunities and AI
BloombergFri, July 31, 2026 at 11:51 PM GMT+3
Illumina CEO Jacob Thaysen discusses the company's earnings, genomic medicine opportunities and the potential for artificial intelligence in life sciences on "Bloomberg The Close."
Yorumlar (0)
Giriş yaparak yorum yazabilirsin.
İlk yorumu sen yaz.